MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Lustra

Company: Medicis Pharmaceutical
Approval Status: Approved January 1998
Treatment for: ultraviolet-induced skin discolorations
Areas: Dermatology / Plastic Surgery

| General Information | Clinical Results | Mechanism of Action |


General Information

Lustra has been approved for the treatment of ultraviolet-induced skin discolorations and hyperpigmentation associated with pregnancy, superficial trauma and the use of oral contraceptives and hormone replacement therapy.


Clinical Results

In clinical studies, Lustra demonstrated substantial reduction in pigmented lesions in a two-week period, and the reservoir effect of Lustra reduced damage from ultraviolet radiation versus placebo.


Mechanism of Action

Lustra contains 4% hydroquinone in a vehicle containing glycolic acid and an antioxidant complex.




< back to top

Lustra Drug Information

The Lustra drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.